ストックスクリーナーアプリを入手
7.54
1.44%
-0.11
前日終値:
$7.65
開ける：
$7.7
24時間の取引高:
97,348
Relative Volume:
0.59
時価総額：
$153.14M
収益：
$56.13M
当期純損益:
$-14.67M
株価収益率:
-10.19
EPS:
-0.74
ネットキャッシュフロー:
$-9.13M
1週間 パフォーマンス:
-1.95%
1か月 パフォーマンス:
+4.29%
6か月 パフォーマンス:
+9.59%
1年 パフォーマンス:
+44.17%
1日の値動き範囲:
$7.45
$7.935
1週間の範囲:
$7.42
$8.18
52週間の値動き範囲:
$3.535
$9.40
Journey Medical Corp Stock (DERM) Company Profile
名前
Journey Medical Corp
セクター
電話
480-434-6670
住所
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
DERM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.54 | 207.59M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | 開始されました | H.C. Wainwright | Buy |
| 2025-07-30 | 再開されました | B. Riley Securities | Buy |
| 2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-28 | 再開されました | ROTH MKM | Buy |
| 2021-12-07 | 開始されました | B. Riley Securities | Buy |
Journey Medical Corp (DERM) 最新ニュース
Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators - Markets Mojo
Will Journey Medical Corporation stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Will Journey Medical Corporation stock see insider buyingMarket Growth Report & Low Volatility Stock Recommendations - newser.com
What Makes Journey Medical Corporation (DERM) a Good Investment? - Yahoo Finance
Detecting price anomalies in Journey Medical Corporation with AIEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
HC Wainwright Forecasts Journey Medical FY2025 Earnings - Defense World
Fortress Biotech reports NDA resubmission for Menkes disease treatment - Investing.com
FY2025 EPS Estimates for Journey Medical Reduced by B. Riley - MarketBeat
FY2025 EPS Forecast for Journey Medical Decreased by Analyst - MarketBeat
Is Journey Medical Corporation forming a reversal patternFed Meeting & Low Drawdown Trading Strategies - newser.com
FY2029 EPS Estimates for Journey Medical Boosted by Analyst - Defense World
What valuation multiples suggest for Journey Medical Corporation stockPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
Can Journey Medical Corporation stock deliver sustainable ROEQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
B. Riley Increases Earnings Estimates for Journey Medical - MarketBeat
HC Wainwright Forecasts Weaker Earnings for Journey Medical - MarketBeat
Can Journey Medical Corporation stock attract ESG capital inflowsTrade Exit Summary & Daily Growth Stock Tips - newser.com
Journey Medical Corp. Hits New 52-Week High of $9.40 - Markets Mojo
Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wall Street analysts’ outlook for Journey Medical Corp (DERM) - Setenews
Fortress Biotech, Inc. (NASDAQ:FBIO) Q3 2025 Earnings Call Transcript - Insider Monkey
Journey Medical (NASDAQ:DERM) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Journey Medical price target raised to $16 from $10 at Alliance Global - TipRanks
Buy Rating for Journey Medical Corp Driven by Emrosi’s Market Success and Growth Potential - TipRanks
Journey Medical Q3 2025 Earnings Call Transcript - MarketBeat
Journey Medical reports Q3 EPS (9c), consensus (4c) - TipRanks
Journey Medical earnings missed by $0.06, revenue fell short of estimates - Investing.com Canada
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: Journey Medical’s Q3 2025 shows revenue jump and strategic growth - Investing.com
Earnings call transcript: Journey Medical Q3 2025 sees revenue growth - Investing.com
Journey Medical Corp SEC 10-Q Report - TradingView
[10-Q] Journey Medical Corp Quarterly Earnings Report | DERM SEC FilingForm 10-Q - Stock Titan
Journey Medical Corporation (DERM) Q3 FY2025 earnings call transcript - Yahoo Finance
Journey Medical Q3 revenue up 21% on increase in Emrosi prescriptions - MarketScreener
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
[8-K] Journey Medical Corp Reports Material Event | DERM SEC FilingForm 8-K - Stock Titan
Journey Medical Corp. Hits New 52-Week High of $9.38 - Markets Mojo
Insights into Journey Medical's Upcoming Earnings - Benzinga
What To Expect From Journey Medical Corp (DERM) Q3 2025 Earnings - GuruFocus
Volume spikes in Journey Medical Corporation stock – what they meanJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Journey Medical Corp (DERM) 財務データ
収益
当期純利益
現金流量
EPS
6.17%
0.67%
大文字化:
|
ボリューム (24 時間):